Silvercrest Asset Management Group »

Lenz Therapeutics shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.8M 175k 16.00